You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

Displaying 205041 - 205050 of 207728 results
  1. Power Analysis for Meta Analysis

    SBC: BIOSTATISTICAL PROGRAMMING ASSOC, INC.            Topic: N/A

    DESCRIPTION (provided by applicant): Meta-analysis plays a key role in setting policy and in planning new research. In the field of substance abuse prevention, meta-analyses have been used to determine the relative impact of competing treatments for addiction, to estimate prevalence of addiction-related diseases, to plan targeted interventions, to assess the cost-effectiveness of competing treatme ...

    SBIR Phase II 2007 Department of Health and Human ServicesNational Institutes of Health
  2. Tissue Perfusion and Blood Flow Monitoring Technology

    SBC: CW OPTICS, INC.            Topic: N/A

    DESCRIPTION (provided by applicant): There is a need to be able to quantify tissue perfusion for the purpose of assessing the viability of ischemic tissue such as wounds and flaps. For wound care in diabetes, early detection of angiogenesis compromise is an important determinant of salvage. This reduces cost, reduces risk of amputation, and increases patient satisfaction. Approximately 10% of all ...

    SBIR Phase II 2007 Department of Health and Human ServicesNational Institutes of Health
  3. Rapid Diagnosis of Monkeypox and Smallpox Infections

    SBC: NAJIT TECHNOLOGIES INC            Topic: N/A

    DESCRIPTION (provided by applicant): Virulent orthopoxviruses (OPV) such as monkeypox and smallpox represent Category A select agents that could be used as biological weapons. Although smallpox is now extinct in nature, it was weaponized by the former Soviet Union and remains a significant concern due to the potential that remaining stocks of this highly contagious virus could fall into the hands ...

    SBIR Phase I 2007 Department of Health and Human ServicesNational Institutes of Health
  4. Angiotensin Analogs to Treat Wound Healing

    SBC: U.S. BIOTEST, INC.            Topic: N/A

    DESCRIPTION (provided by applicant): Americans suffer from chronic wounds associated with diabetic, pressure and venous stasis ulcers. In many cases, chronic wounds can take years to heal, have a high recurrence rate and will result in amputations for 54,000 patients annually. It is estimated that 2.2 million patients in the United States have chronic ulcers that don't respond to conventional ther ...

    SBIR Phase II 2007 Department of Health and Human ServicesNational Institutes of Health
  5. WSTDtv: Adolescent Multimedia STD Prevention Curriculum

    SBC: ACADEMIC EDGE, INC.            Topic: N/A

    DESCRIPTION (provided by applicant): Sexually active adolescents have the highest rates of STD of any age group. The WSTDtv project addresses the need for a readily available, developmentally appropriate, engaging, and effective HIV/STD awareness and prevention curriculum for schools. By combining multimedia activities, web-based resources, and electronic and print teacher support tools and strate ...

    SBIR Phase II 2007 Department of Health and Human ServicesNational Institutes of Health
  6. Intrathecal Cyclosporin for the Treatment of Amyotrophic Lateral Sclerosis (ALS)

    SBC: MAAS BIOLAB, INC.            Topic: N/A

    DESCRIPTION (provided by applicant): The scientific research proposed, the determination of pre-clinical stability, pharmacokinetics and toxicology testing of Maas BiolAB's proprietary cyclosporin intrathecal formulation, Mitogard(tm), will allow the company to file for Investigational New Drug (IND) approval with the Food and Drug Administration (FDA) and begin human clinical trials for amyotroph ...

    SBIR Phase II 2007 Department of Health and Human ServicesNational Institutes of Health
  7. Rapid Detection of Bacterial Contamination in Platelets

    SBC: BIOSENSE TECHNOLOGIES, INC.            Topic: N/A

    DESCRIPTION (provided by applicant): A new approach for detecting pathogenic bacteria in platelet concentrates rapidly is proposed. Technically, the approach is based on an unconventional implementation of impedance sensing to monitor cellular metabolic responses with exceptional sensitivity and stability. This enables the detection of small numbers of viable aerobic and anaerobic microorganisms i ...

    SBIR Phase II 2007 Department of Health and Human ServicesNational Institutes of Health
  8. Improved Preservation of Suspended Cells

    SBC: CELL PRESERVATION SERVICES INC            Topic: N/A

    Cell Preservation Services, Inc. (CPSI) is dedicated to the development of novel processes and devices in the area of biotechnology and medicine. CPSI research strategy focuses on understanding and manipulating the cell survival and cell death pathways activated in response to various stressors. Recently, we have recognized that it is not adequate to merely address stress response issues during i ...

    SBIR Phase II 2007 Department of Health and Human ServicesNational Institutes of Health
  9. A BREATH TEST FOR LUNG CANCER

    SBC: MENSSANA RESEARCH INC            Topic: N/A

    DESCRIPTION (provided by applicant): Background: Primary carcinoma of the lung is the leading cause of cancer death in the United States. A test that detects early-stage disease could potentially reduce the number of deaths. A breath test for volatile organic compounds (VOCs) was sensitive and specific for primary lung cancer in two multicenter clinical studies. A third multicenter study confirmed ...

    SBIR Phase II 2007 Department of Health and Human ServicesNational Institutes of Health
  10. Treatment of Chroinc Pain Using Real Time Functional MRI

    SBC: Omneuron            Topic: N/A

    DESCRIPTION (provided by applicant): This research program will conduct a randomized, controlled, multi-site clinical trial of novel investigative therapeutic technology and methods for treating chronic pain in patients refractory to prior treatment modalities to: training the patients to control their chronic pain using real-time functional magnetic resonance imaging (rtfMRI). This work is the ...

    SBIR Phase II 2007 Department of Health and Human ServicesNational Institutes of Health
US Flag An Official Website of the United States Government